12
Views
63
CrossRef citations to date
0
Altmetric
Gene Expression

Identification of a Novel AU-Rich Element in the 3′ Untranslated Region of Epidermal Growth Factor Receptor mRNA That Is the Target for Regulated RNA-Binding Proteins

, , , , &
Pages 2070-2084 | Received 29 Sep 2000, Accepted 19 Dec 2000, Published online: 28 Mar 2023

REFERENCES

  • Anant, S., and N. O. Davidson. 2000. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for apobec-1: binding of apobec-1 to this motif in the 3′ untranslated region of c-myc increases mRNA stability. Mol. Cell. Biol. 20:1982–1992.
  • Belasco, J.. 1993. mRNA degradation in prokaryotic cells: an overview. Control of messenger RNA stability.. J. Belasco, and G. Brawerman. 3–12. Academic Press, San Diego, Calif
  • Bjorge, J. D., A. J. Paterson, and J. E. Kudlow. 1989. Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-alpha in a breast cancer cell line. J. Biol. Chem. 264:4021–4027.
  • Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1991. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11:3288–3295.
  • Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1992. AU RNA-binding factors differ in their binding specificities and affinities. J. Biol. Chem. 267:6302–6309.
  • Brewer, G.. 1991. An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11:2460–2466.
  • Chen, F. Y., F. M. Amara, and J. A. Wright. 1994. Defining a novel ribonucleotide reductase R1 mRNA cis element that binds to a unique cytoplasmic trans-acting protein. Nucleic Acids Res. 22:4796–4797.
  • Chen, C. Y., T. M. Chen, and A. B. Shyu. 1994. Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA-destabilizing function. Mol. Cell. Biol. 14:416–426.
  • Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465–470.
  • Chen, C. Y., F. De Gatto-Konczak, Z. Wu, and M. Karin. 1998. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280:1945–1949.
  • Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
  • Clark, A. J. L., S. Ishii, N. Richert, G. T. Merlino, and I. Pastan. 1985. Epidermal growth factor regulates the expression of its own receptor. Proc. Natl. Acad. Sci. USA 82:8374–8378.
  • Cleveland, D. W., and T. J. Yen. 1989. Multiple determinates of eukaryotic mRNA stability. New Biol. 1:121–126.
  • Davis, R. J., and M. P. Czech. 1985. Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654. Proc. Natl. Acad. Sci. USA 82:1974–1978.
  • DeMaria, C. T., and G. Brewer. 1996. AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. J. Biol. Chem. 271:12179–12184.
  • DeMaria, C. T., Y. Sun, L. Long, B. J. Wagner, and G. Brewer. 1997. Structural determinants in AUF1 required for high affinity binding to A+U-rich elements. J. Biol. Chem. 272:27635–27643.
  • Downward, J., Y. Yarden, E. Mayes, G. Scarce, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger, and M. D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307:521–527.
  • Fan, X. C., and J. A. Steitz. 1998. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl. Acad. Sci. USA 95:15293–15298.
  • Fernandez-Pol, J. A., P. D. Hamilton, and D. J. Klos. 1989. Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor beta 1, and triiodothyronine in MDA-MB-468 cells. J. Biol. Chem. 264:4151–4166.
  • Fernandez-Pol, J. A.. 1991. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells. Crit. Rev. Oncog. 2:173–185.
  • Filmus, J., M. N. Pollak, R. Cailleau, and R. N. Buick. 1985. MDA-MB-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun. 128:898–905.
  • Ford, L. P., J. Watson, J. D. Keene, and J. Wilusz. 1999. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev. 13:188–201.
  • Gillis, P., and J. S. Malter. 1991. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs. J. Biol. Chem. 266:3172–3177.
  • Gorospe, M., and C. Baglioni. 1994. Degradation of unstable interleukin-1 alpha mRNA in a rabbit reticulocyte cell-free system. Localization of an instability determinant to a cluster of AUUUA motifs. J. Biol. Chem. 269:11845–11851.
  • Iwai, Y., M. Bickel, D. H. Pluznik, and R. B. Cohen. 1991. Identification of sequences within the murine granulocyte-macrophage colony-stimulating factor mRNA 3′-untranslated region that mediate stabilization induced by mitogen treatment of EL-4 thymoma cells. J. Biol. Chem. 266:17959–17965.
  • Jain, R. G., L. G. Andrews, K. M. McGowan, P. H. Pekala, and J. D. Keene. 1997. Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3–L1 adipocytes. Mol. Cell. Biol. 17:954–962.
  • Joseph, B., M. Orlian, and H. Furneaux. 1998. P21(waf1) mRNA contains a conserved element in its 3′-untranslated region that is bound by the Elav-like mRNA-stabilization proteins. J. Biol. Chem. 273:20511–20516.
  • Kesavan, P., S. Mukhopadhayay, S. Murphy, M. Rengaraju, M. A. Lazer, and M. Das. 1991. Thyroid hormone decreases the expression of epidermal growth factor receptor. J. Biol. Chem. 266:10282–10286.
  • King, C. R., M. H. Kraus, L. T. Williams, G. T. Merlino, I. H. Pastan, and S. A. Aaronson. 1985. Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs. Nucleic Acids Res. 13:8477–8486.
  • Klijn, J. G., P. M. Berns, P. I. Schmitz, and J. A. Foekens. 1992. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocrine Rev. 13:3–17.
  • Kontoyiannis, D., M. Pasparakis, T. T. Pizarro, F. Cominelli, and G. Kollias. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10:387–398.
  • Kudlow, J. E., C. Y. Cheung, and J. D. Bjorge. 1986. Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line. J. Biol. Chem. 26:4134–4138.
  • Lafon, I., F. Carballes, G. Brewer, M. Poiret, and D. Morello. 1998. Developmental expression of AUF1 and HUR, two c-myc mRNA binding proteins. Oncogene 16:3413–3421.
  • Lagnado, C. A., C. Y. Brown, and G. J. Goodall. 1994. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14:7984–7995.
  • Leedman, P. J., A. R. Stein, and W. W. Chin. 1995. Regulated specific protein binding to a conserved region of the 3′-untranslated region of thyrotropin beta-subunit mRNA. Mol. Endocrinol. 9:375–387.
  • Leedman, P. J., A. R. Stein, W. W. Chen, and J. T. Rogers. 1996. Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J. Biol. Chem. 271:12017–12023.
  • Levine, T. D., F. Gao, P. H. King, L. G. Andrews, and J. D. Keene. 1993. Hel-N1: an autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 13:3494–3504.
  • Levy, N. S., S. Chung, H. Furneaux, and A. P. Levy. 1998. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273:6417–6423.
  • Libermann, T. A., H. R. Nusbaum, N. Razon, R. Kris, I. Lax, H. Soreq, N. Whittle, M. D. Waterfield, A. Ullrich, and J. Schlessinger. 1985. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial organ. Nature 313:144–147.
  • Lin, C. R., W. S. Chen, W. Kruiger, L. S. Stolarsky, W. Weber, R. M. Evans, I. M. Verma, G. N. Gill, and M. G. Rosenfeld. 1984. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science 224:843–848.
  • Ma, W. J., S. Cheng, C. Campbell, A. Wright, and H. Furneaux. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271:8144–8151.
  • Malter, J. S.. 1989. Identification of an AUUUA-specific messenger RNA binding protein. Science 246:664–666.
  • Malter, J. S., and Y. Hong. 1991. A redox switch and phosphorylation are involved in the post-translational up-regulation of the adenosine-uridine binding factor by phorbol ester and ionophore. J. Biol. Chem. 266:3167–3171.
  • Maurer, F., M. Tierney, and R. L. Medcalf. 1999. An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucleic Acids Res. 27:1664–1673.
  • McCulloch, R. K., C. E. Walker, A. Chakera, J. Jazayeri, and P. J. Leedman. 1998. Regulation of EGF-receptor expression by EGF and TGF alpha in epidermoid cancer cells is cell type-specific. Int. J. Biochem. Cell. Biol. 30:1265–1278.
  • Merlino, G. T., Y. H. Xu, S. Ishii, A. J. Clark, K. Semba, K. Toyoshima, T. Yamamoto, and I. Pastan. 1984. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science 224:417–419.
  • Morris, G. L., and J. D. Dodd. 1990. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J. Urol. 143:1272–1274.
  • Myer, V. E., X. C. Fan, and J. A. Steitz. 1997. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 16:2130–2139.
  • Nakagawa, J., H. Waldner, S. Meyer-Monard, J. Hofsteenge, P. Jeno, and C. Moroni. 1994. AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc. Natl. Acad. Sci. USA 92:2051–2055.
  • Nakamaki, T., J. Imamura, G. Brewer, N. Tsuruoka, and H. P. Koeffler. 1995. Characterization of adenosine-uridine-rich RNA binding factors. J. Cell. Physiol. 165:484–492.
  • Peltz, S. W., G. Brewer, P. Bernstein, P. A. Hart, and J. Ross. 1991. Regulation of mRNA turnover in eukaryotic cells. Crit. Rev. Eukaryot. Gene Expr. 1:99–126.
  • Rosenthal, N.. 1987. Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol. 152:704–720.
  • Sainsbury, J. R., J. R. Farndon, G. V. Sherbet, and A. L. Harris. 1985. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet i:364–366.
  • Schalinske, K. L., and R. S. Eisenstein. 1996. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells. J. Biol. Chem. 271:7168–7176.
  • Seth, D., K. Shaw, J. Jazayeri, and P. J. Leedman. 1999. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Br. J. Cancer 80:657–669.
  • Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659–667.
  • Sheikh, M. S., Z. M. Shao, J. C. Chen, X. S. Li, A. Hussain, and J. A. Fontana. 1994. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression. J. Cell. Biochem. 54:289–298.
  • Thomson, A. M., J. T. Rogers, C. E. Walker, J. M. Staton, and P. J. Leedman. 1999. Optimized RNA gel-shift and UV cross-linking assays for characterization of cytoplasmic RNA-protein interactions. BioTechniques 27:1032–1042.
  • Toi, M., T. Tominaga, A. Osaki, and T. Toge. 1994. Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study. Breast Cancer Res. Treat. 29:51–59.
  • Vakalopoulou, E., J. Schaack, and T. Shenk. 1991. A 32-kilodalton protein binds to AU-rich domains in the 3′ untranslated regions of rapidly degraded mRNAs. Mol. Cell. Biol. 11:3355–3364.
  • Wilson, G. M., and G. Brewer. 1999. Identification and characterization of proteins binding A+U-rich elements. Methods 17:74–83.
  • Wittor, H., H. Leying, A. Hochhaus, and R. V. Miltenburg. 2000. Real-time quantitation of BCR-ABL mRNA transcripts using the LightCycler -t(9;22) Quantification Kit. Biochemica, no. 2 Roche Diagnostics Corp., Indianapolis, Ind
  • Xu, Y. H., S. Ishii, A. J. Clark, M. Sullivan, R. K. Wilson, D. P. Ma, B. A. Roe, G. T. Merlino, and I. Pastan. 1984. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature 309:806–810.
  • Yamamoto, T., T. Nishida, N. Miyajima, S. Kawai, T. Ooi, and K. Toyoshima. 1983. The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell 35:71–78.
  • Yeap, B. B., R. G. Krueger, and P. J. Leedman. 1999. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology 140:3282–3291.
  • You, Y., C. Y. Chen, and A. B. Shyu. 1992. U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 3′ untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol. Cell. Biol. 12:2931–2940.
  • Zhang, W., B. J. Wagner, K. Ehrenman, A. W. Schaefer, C. T. De-Maria, D. Crater, K. DeHaven, L. Long, and G. Brewer. 1993. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 12:7652–7665.
  • Zubiaga, A. M., J. G. Belasco, and M. E. Greenberg. 1995. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15:2219–2230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.